Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Lilly, which sells the Alzheimer’s drug Kisunla, has recruited Moore to its global “Brain Health Matters” campaign. Drawing ...

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform. | Eli Lilly is inviting early-stage biotechs to make use of drug ...

In eagerly awaited results from a new study, the pharmaceutical company Eli Lilly reports that a pill its scientists developed causes people who are overweight or obese, but not diabetic, to lose ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

Eli Lilly's robust R&D, strong pipeline, and leadership in diabetes, obesity, and oncology underpin its long-term growth ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.